Agios Announces the Planned Retirement of Chief Scientific Officer, Scott Biller, Ph.D., Effective December 31, 2019

NEXT STORY
FibroGen Appoints Suzanne Blaug to Board of Directors
PREV STORY
AB Science is providing a summary of the web conference held on June 5, 2019
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global $19.4 Bn Gene Expression Markets to 2028 – Rise in Investments for the Development of Alternative Drug Discovery Approaches

author_avatar
NASDAQ Market News

Chembio Diagnostics Completes Acquisition of Orangelife

author_avatar
NASDAQ Market News

Telix Pharmaceuticals and Memorial Sloan Kettering Cancer Center Announce Renal Cancer Collaboration

MELBOURNE, Australia and NEW YORK, Dec. 14, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited ...

author_avatar
NASDAQ Market News